Citation only
via Europe PMC
Peroxisomes in Alzheimer's disease: emerging mechanistic insights and therapeutic opportunities.
Liu T, Liu Y, Zhang Y, Wang J, Ren Y, Fu S, Han L, Jiang P, Chen J, Li Y, Luo H.
Frontiers in aging neuroscience · 2026
Abstract
Alzheimer's disease (AD) is characterized by amyloid-<i>β</i> (Aβ) deposition, tau pathology, synaptic injury, neuroinflammation, oxidative stress, and disrupted organellar homeostasis. Peroxisomes maintain lipid and redox balance through very-long-chain fatty acid (VLCFA) <i>β</i>-oxidation, plasmalogen biosynthesis, and reactive oxygen species (ROS) metabolism. This Review evaluates how peroxisomal alterations may modulate APP processing and Aβ clearance, tau kinase/phosphatase balance, neuroinflammation, oxidative stress, and peroxisome-mitochondria crosstalk. We distinguish human correlational evidence from intervention studies in AD models and mechanistic extrapolation from primary peroxisomal disorders. Current evidence supports a context-dependent vulnerability or amplifier model rather than a universal causal pathway. Peroxisome-targeted interventions remain investigational, and no validated biomarker currently identifies an AD subgroup for such treatment.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.3389/fnagi.2026.1960320
- Canonical
- link ↗
- Fetched
- 2026-10-17 MST
Cite this
APA
T, L., Y, L., Y, Z., J, W., Y, R., S, F., L, H., P, J., J, C., Y, L., & H., L. (2026). Peroxisomes in Alzheimer's disease: emerging mechanistic insights and therapeutic opportunities. <em>Frontiers in aging neuroscience</em>. https://doi.org/10.3389/fnagi.2026.1960320
Vancouver
T L, Y L, Y Z, J W, Y R, S F, et al. Peroxisomes in Alzheimer's disease: emerging mechanistic insights and therapeutic opportunities. Frontiers in aging neuroscience. 2026. doi:10.3389/fnagi.2026.1960320.
BibTeX
@article{liu2026Peroxi,
title = {Peroxisomes in Alzheimer's disease: emerging mechanistic insights and therapeutic opportunities.},
author = {Liu T and Liu Y and Zhang Y and Wang J and Ren Y and Fu S and Han L and Jiang P and Chen J and Li Y and Luo H.},
journal = {Frontiers in aging neuroscience},
year = {2026},
doi = {10.3389/fnagi.2026.1960320},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Cells 2026
Open access · OA
Peroxisomes in Aging: Guardians of Cellular Resilience and Function.
Frontiers in Pharmacology 2023
Open access · CC-BY
From imbalance to impairment: the central role of reactive oxygen species in oxidative stress-induced disorders and therapeutic exploration
Alzheimer s & Dementia 2011
Citation only
P2‐301: The mTOR pathway in Alzheimer's disease
Journal of Clinical Investigation 2006
Open access · OA
Oxidative stress mediates tau-induced neurodegeneration in Drosophila
Biochimie 2013
Preprint · OA
Peroxisomal metabolism and oxidative stress
bioRxiv (Cold Spring Harbor Laboratory) 2021
Preprint · CC-BY